Kodiak Sciences Stock Today

KOD Stock  USD 2.61  0.08  2.97%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 77

 
High
 
Low
High
Kodiak Sciences is trading at 2.61 as of the 19th of June 2024, a -2.97 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.61. Kodiak Sciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Kodiak Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of May 2024 and ending today, the 19th of June 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
4th of October 2018
Category
Healthcare
Classification
Health Care
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. Kodiak Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 52.53 M outstanding shares of which 2.23 M shares are now shorted by investors with about 6.44 days to cover. More on Kodiak Sciences

Moving together with Kodiak Stock

  0.61EXEL Exelixis Potential GrowthPairCorr
  0.67EYEN EyenoviaPairCorr
  0.79BMY Bristol Myers SquibbPairCorr

Moving against Kodiak Stock

  0.6ELDN Eledon Pharmaceuticals Earnings Call TomorrowPairCorr
  0.46RNAZ Transcode TherapeuticsPairCorr
  0.44MRK Merck Company Financial Report 6th of August 2024 PairCorr
  0.42LLY Eli LillyPairCorr
  0.41HOOK Hookipa PharmaPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Kodiak Stock Highlights

ESG Sustainability
Environmental
Governance
Social
PresidentHong Liang
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities30 M41.7 M
Way Down
Slightly volatile
Non Current Liabilities Total112.3 M171.9 M
Way Down
Slightly volatile
Total Assets492.8 M479.4 M
Fairly Up
Slightly volatile
Total Current Assets402 M289.3 M
Significantly Up
Slightly volatile
Kodiak Sciences can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Kodiak Sciences' financial leverage. It provides some insight into what part of Kodiak Sciences' total assets is financed by creditors.
Liquidity
Kodiak Sciences has 181.63 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Kodiak Sciences has a current ratio of 8.48, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Kodiak to invest in growth at high rates of return.

Investments

261.69 Million
Kodiak Sciences (KOD) is traded on NASDAQ Exchange in USA. It is located in 1200 Page Mill Road, Palo Alto, CA, United States, 94304 and employs 107 people. Kodiak Sciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 141.32 M. Kodiak Sciences runs under Biotechnology sector within Health Care industry. The entity has 52.53 M outstanding shares of which 2.23 M shares are now shorted by investors with about 6.44 days to cover. Kodiak Sciences has about 597.88 M in cash with (154.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Kodiak Sciences Probability Of Bankruptcy
Ownership Allocation
Kodiak Sciences maintains a total of 52.53 Million outstanding shares. The majority of Kodiak Sciences outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Kodiak Sciences to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Kodiak Sciences. Please pay attention to any change in the institutional holdings of Kodiak Sciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kodiak Ownership Details

Kodiak Stock Institutional Holders

InstituionRecorded OnShares
State Street Corporation2024-03-31
747.5 K
Geode Capital Management, Llc2024-03-31
723 K
Amvescap Plc.2024-03-31
705.3 K
Board Of Ttees Leland Stanford Jr Univ2024-03-31
691.8 K
Hudson Bay Capital Management Lp2024-03-31
625 K
Renaissance Technologies Corp2024-03-31
581.4 K
Jacobs Levy Equity Management, Inc.2024-03-31
525.6 K
Ikarian Capital, Llc2024-03-31
476.6 K
Dimensional Fund Advisors, Inc.2024-03-31
426.7 K
Baker Bros Advisors Lp2024-03-31
17.3 M
Blackrock Inc2024-03-31
3.9 M
View Kodiak Sciences Diagnostics

Kodiak Sciences Historical Income Statement

At present, Kodiak Sciences' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Depreciation And Amortization is expected to grow to about 27.2 M, whereas Gross Profit is projected to grow to (24.6 M). View More Fundamentals

Kodiak Stock Against Markets

Kodiak Sciences Corporate Management

Tracy ChienVP ControllerProfile
Almas MScSenior OperationsProfile
Victor MDChairman, CoFounderProfile
Michael LouieSenior OfficerProfile
CPA MBACFO VPProfile
Pablo MDSenior DevelopmentProfile
Stephen RaillardSenior ManufacturingProfile

Additional Information and Resources on Investing in Kodiak Stock

When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.44)
Return On Assets
(0.29)
Return On Equity
(0.73)
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.